Susquehanna International Group
TBRA

Susquehanna International Group’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Susquehanna International Group’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-18,200
Closed -$723K – 10607
2016
Q3 		$723K Buy
+18,200
New +$203K ﹤0.01% 5410
2015
Q4 		– Sell
-15,000
Closed -$145K – 10410
2015
Q3 		$145K Sell
15,000
-5,000
-25% -$70.2K ﹤0.01% 8948
2015
Q2 		$345K Buy
20,000
+18,000
+900% +$263K ﹤0.01% 8305
2015
Q1 		$22K Buy
+2,000
New +$21.5K ﹤0.01% 9267

Susquehanna International Group's TBRA Position: Q4 2016 in Review

Susquehanna International Group sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 159,374 shares — an estimated $6.33M sold.

Susquehanna International Group first reported a position in TBRA in Q1 2014 and held it in 4 quarters. The position peaked at $6.33M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

  • Susquehanna International Group reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Susquehanna International Group sold 159,374 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $6.33M.
  • Susquehanna International Group first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2014 and held it in 4 quarters.
  • Susquehanna International Group's Tobira Therapeutics, Inc. Common Stock position peaked at $6.33M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.